ipolar affective disorder, type I (BP-I) is a severe mental illness marked by periodic extremes of mood state (manias), as well as (in most cases) episodes of depression and (in many cases) psychosis. The consequences of BP-I are severe, and involve both direct and indirect issues. Rates of suicide in BP-I patients are high, 1,2 and BP-I subjects also suffer from poorer quality of life and lower productivity than unaffected individuals.3 Annual public health costs (combined direct and indirect) of BP have been estimated to be between 24 billion and 45 billion dollars.4,5 BP-I occurs in all populations that have been studied, with lifetime prevalence rates worldwide of the order of one per every 100 individuals. 6 Segregation analyses, adoption studies, and twin studies have consistently shown that, regardless of the population studied, genetic factors play an important role in determining one's risk of developing BP-I. [7][8][9] Since little is known about the actual etiology of BP, it would be a major contribution to our understanding of the pathophysiology of BP if the genes responsible for the neurobiologic changes which underlie this disorder could be identified. The difficulty in finding genetic loci that are involved in BP most likely derives from the complex nature of the illness. When multiple transmission models for BP-I (the most severe form of BP) have been tested, oligogenic epistatic models are found to be the best fit, rather than models which purport one major locus. Craddock et al 10 reviewed epidemiologic, family, and twin studies, and showed that two, three, or four locus models
141T r a n s l a t i o n a l r e s e a r c h B